Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques

Deng, Wei, Bao, Linlin, Liu, Jiangning, Xiao, Chong, Liu, Jiayi, Xue, Jing, Lv, Qi, Qi, Feifei +19 more·2020·Science
DOI 10.1126/science.abc5343

Cited by (432)

Items 301–400 of 432

  1. The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
    Yifei Wang, Tian Qin, Lilin Ye · 2022 · Frontiers in Cellular and Infection Microbiology
  2. A longitudinal comparison of spike and nucleocapsid SARS-CoV-2 antibody responses in a tertiary hospital’s laboratory workers with validation of DBS specimen analysis
    Isa Murrell, Dónall Forde, L Tyson, Lee Chichester, A Garratt, Owen Vineall, Natalie Palmer, Ruth E. Jones, Catherine Moore · 2020 · medRxiv
  3. A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions
    Yao Yu Yeo, Yao-Rui Yeo, Wan-Jin Yeo · 2020 · Experimental Results
  4. Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination
    Catherine Byrne, Joshua Tisdell Schiffer · 2024 · Frontiers in Immunology
  5. Bienestar subjetivo, depresión y ansiedad en estudiantes de la Ciudad de Guatemala
    Sindy S. Linares, Katherin J. Orantes, Gabriela A. Linares, Héctor M. Muñoz-Alonzo, Donald W. González-Aguilar · 2022 · Ciencias Sociales y Humanidades
  6. T cell responses to adenoviral vectors expressing the SARS-CoV-2 nucleoprotein.
    Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, Arezki Chekaoui, Dakota Newman, Xiang Zhou, Hildegund C.J. Ertl · 2021 · PubMed
  7. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
  8. SARS-CoV-2 seroprevalence among employees of a university hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study)
    Deborah De Geyter, Ellen Vancutsem, Sven Van Laere, Denis Piérard, Patrick Lacor, Ilse Weets, Sabine Danielle Allard · 2021 · Epidemiology and Infection
  9. Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques
    Patrick Madden, M. S. Arif, Mark E. Becker, Michael D. McRaven, A. M. Carias, R. Lorenzo-Redondo, Si-Xia Xiao, C. Midkiff, R. Blair, E. L. Potter et al. · 2021 · Frontiers in Immunology
  10. Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
    Aiquan Chang, Jingyou Yu · 2022 · Viruses
  11. COVID-19: A Veterinary and One Health Perspective
    Deepak Kumar, J. Bayry, N. Hegde · 2022 · Journal of the Indian Institute of Science
  12. Subgenomic RNAs and Their Encoded Proteins Contribute to the Rapid Duplication of SARS-CoV-2 and COVID-19 Progression
    Yifan Zhang, Xinglong Zhang, Huiwen Zheng, Longding Liu · 2022 · Biomolecules
  13. SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
    Ziwei Li, Tiandan Xiang, Boyun Liang, Jing Liu, Hui Deng, Xuecheng Yang, Hua Wang, Xuemei Feng, Gennadiy Zelinskyy, Mirko Trilling et al. · 2023 · Virologica Sinica
  14. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
    Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
  15. COVID-19, Australia: Epidemiology Report 24 (Fortnightly reporting period ending 30 August 2020).
    COVID-19 National Incident Room Surveillance Team · 2020 · Communicable diseases intelligence
  16. Plausible Explanation for the Third COVID-19 Wave in India and Its Implications
    S. Triambak, D. P. Mahapatra, N. Barik, A. Chutjian · 2022 · Infectious Disease Modelling
  17. Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases
    Jason Li, Jing Wang, Hu Wang · 2023 · ACS Pharmacology & Translational Science
  18. Emerging COVID-19 reinfection four months after primary SARS-CoV-2 infection
    H. Salzer, Matthias J. Neuböck, S. Heldt, I. Haug, C. Paar, B. Lamprecht · 2021 · Wiener Medizinische Wochenschrift
  19. An overview of preclinical animal models for SARS-CoV-2 pathogenicity
    Itti Munshi, Aditya Khandvilkar, Shrinivas Chavan, G. Sachdeva, S. Mahale, U. Chaudhari · 2021 · The Indian journal of medical research
  20. An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
    Liang Zhang, Shuai-Yin Chen, Wei-Guo Zhang, Hai-Yan Yang, Yuefei Jin, Guang-Cai Duan · 2021 · Frontiers in Microbiology
  21. Organs on chips: fundamentals, bioengineering and applications
    Nasser K. Awad · 2024 · Journal of Artificial Organs
  22. Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species
    Leira Fernández-Bastit, S. Marfil, Edwards Pradenas, Julian Blanco, J. Vergara-Alert, J. Segalés · 2025 · Viruses
  23. COVID-19, Australia: Epidemiology Report 22 (Fortnightly reporting period ending 2 August 2020).
    COVID-19 National Incident Room Surveillance Team · 2020 · Communicable diseases intelligence
  24. Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
    Dipa Rani Roy, Md. Mosfequr Rahman, Arnaba Saha Chaity, Md Abu Reza, Ariful Haque · 2022 · Scientific Reports
  25. Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant
    Wenwen He, Huan Cui, Shen Wang, Bo Liang, Cheng Zhang, Weiqi Wang, Qi Wang, Wu-Jian Li, Yong-Kun Zhao, Tie-Cheng Wang et al. · 2023 · Microorganisms
  26. The panzootic potential of SARS-CoV-2
    Makenzie E. Mabry, Angela Fanelli, C. Mavian, A. Lorusso, Costanza Manes, P. Soltis, Ilaria Capua · 2023 · BioScience
  27. Monitoring the Cascade of Monocyte-Derived Macrophages to Influenza Virus Infection in Human Alveolus Chips
    Chenguang Wang, Shujun Liu, Chuyu Li, Zhongjie Wang, Ruiqi Ming, Lili Huang · 2024 · ACS Applied Materials & Interfaces
  28. Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque
    Ge Gao, Xue Hu, Yiwu Zhou, Ju-Hong Rao, Xiao-Yu Zhang, Yun Peng, Jia-Xuan Zhao, Yan-Feng Yao, Kun-Peng Liu, Mengying Liang et al. · 2022 · Virologica Sinica
  29. SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection
    Dakai Liu, George David Rodriguez, Hangyu Zhou, Ye‐Xiao Cheng, Xiaofeng Li, Wenwen Tang, Nishant Prasad, Chun-Cheng Chen, Vishnu Singh, Eric Konadu et al. · 2022 · International Journal of Molecular Sciences
  30. Can COVID-19 strike twice?
    Ashley York · 2020 · Nature Reviews Microbiology
  31. COVID-19: individual and herd immunity
    Jean‐François Bach, Patrick Berche, Lucienne Chatenoud, Dominique G. Costagliola, Alain‐Jacques Valleron · 2021 · Comptes Rendus Biologies
  32. Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2
    Xiaorong Huang, Chumin Liang, Manman Li, Huimin Chen, Zhaowan Li, Qianqian Ruan, Ximing Hu, Lilian Zeng, Huifang Lin, Wei Zhao et al. · 2023 · Vaccines
  33. Rise of Macaque Models for Immunity and Infection Research
    Arpan Acharya, Siddappa N. Byrareddy · 2024 · Springer eBooks
  34. Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
    Liat Bar‐On, Moshe Aftalion, Efi Makdasi, David Gur, Ron Alcalay, Hila Cohen, Adi Beth-Din, Ronit Rosenfeld, Hagit Achdout, Erez Bar‐Haim et al. · 2022 · Vaccines
  35. Association between the Demographic Characteristics of Patients and the Severity of COVID-19
    Hayder Fadhil Okab · 2023 · University of Thi-Qar Journal of Science
  36. Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2
    Subeena Sood, Ebony Nicole Gary, Majed M. Matar, Jessica Kim, Casey E. Hojecki, Bryce M. Warner, Robert Vendramelli, Thang Truong, Alanna Smith, Jennifer S. Rice et al. · 2025 · Frontiers in Immunology
  37. CRISPR-based assay reveals SARS-CoV-2 RNA dynamic changes and redistribution patterns in non-human primate model
    Zhen Jian Huang, Lili Zhang, Christopher J. Lyon, Bo Ning, Brady M. Youngquist, Alex Niu, Brandon J. Beddingfield, Nicholas J. Maness, Nakhle S. Saba, Chenzhong Li et al. · 2022 · Emerging Microbes & Infections
  38. Broad Spectrum Antiviral Therapy can Supersede Vaccination Strategy for Combating COVID-19 Pandemic
    Ashok K. Chakraborty · 2021 · Medical Journal of Clinical Trials & Case Studies
  39. Era of the 4D animal model
    Lihong Zhang, Jindan Guo, Jiangning Liu · 2023 · Animal Models and Experimental Medicine
  40. SARS-CoV-2 Vaccine
    Karrie A.B. Walker · 2020 · Global Reproductive Health
  41. Development of an anti‐SARS‐CoV‐2 monoclonal antibody panel and its applicability as a reagent in high‐throughput fluorescence reduction neutralization and immunohistochemistry assays
    Gabriela Mattoso Coelho, Allan Henrique Depieri Cataneo, Sônia Mara Raboni, Meri Bordignon Nogueira, Caroline Busatta Vaz de Paula, Ana Clara Almeida, Vanessa Zulkievicz Rogerio, Nilson Ivo Tonin Zanchin, Lúcia de Noronha, Camila Zanluca et al. · 2023 · Journal of Medical Virology
  42. Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection
    Rupendra SHRESTHA, Reena Shrestha, R. Khadka, R. Gyawali · 2021 · JNMA; journal of the Nepal Medical Association
  43. Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
    Grigore Mihăescu, Mariana Carmen Chifiriuc, Corneliu Ovidiu Vrâncianu, Marian Constantin, Roxana Filip, Mihaela Roxana Popescu, Liliana Burlibaşa, Anca Cecilia Nicoară, Alexandra Bolocan, Ciprian Iliescu et al. · 2021 · Microorganisms
  44. COVID-19;-The origin, genetics,and management of the infection of mothers and babies
    Hassan I. El‐Sayyad, Yousef K. A. Abdalhafid · 2020 · Egyptian Journal of Basic and Applied Sciences
  45. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
    Shen Wang, Ling Li, Fei-Hu Yan, Yu-Wei Gao, Song-Tao Yang, X. Xia · 2021 · Vaccines
  46. Post Pandemic Problem, is there an animal model suitable to investigate PASC
    Julia van der Bie, Anthony Coléon, Denise Visser, Willy M J M Bogers, Jeroen den Dunnen, Henri M.H. Spronk, Jan A. M. Langermans, Hanneke L.D.M. Willemen, Guilherme Dias de Melo, Jinte Middeldorp et al. · 2025 · npj Imaging
  47. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution
    Tom Gallagher, Paul B. McCray · 2021 · PLoS Biology
  48. De l’origine encore incertaine de la Covid-19 au risque d’un réservoir animal du SARS-Cov2 ou de ses variants dans le futur : une revue
    Jeanne Brugère‐Picoux, Eric Maurice Leroy, Serge Georges Rosolen, Jean-Luc Angot, Yves Buisson · 2021 · Bulletin de l Académie vétérinaire de France
  49. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection
    Heng Li, Xin Zhao, Jing Li, Hui-Wen Zheng, Yu-Rong Zhao, Jin-Ling Yang, Jing-Xian Zhou, Fengmei Yang, Yan-Li Chen, Yuanyuan Zuo et al. · 2022 · Viruses
  50. Protein-coding gene interaction network prediction of bioactive plant compound action against SARS-CoV-2: a novel hypothesis using bioinformatics analysis
    Eliane Macedo Sobrinho, Hércules Otacílio Santos, Ernane Ronie Martins, Francine Souza Alves da Fonseca, Lucyana Conceição Farias, Charles Martins Aguilar, Ulisses Alves Pereira, Nilson Nicolau-Júnior, Matheus de Souza Gomes, Cintya Neves de Souza et al. · 2022 · Anais da Academia Brasileira de Ciências
  51. COVID-19 VE HAYVANLAR
    Ahmet Kursat Azkur · 2020 · Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni
  52. Realization of humoral immunity against SARS-CoV-2 infections
    Yong Lin, Zhenyu Zhao, Jiaxin Zheng, Jia Liu, Ailong Huang · 2021 · Fundamental Research
  53. Dialectics and dilemmas arising from Covid-19 immunity testing: presenting a workforce management paradox
    Steven Davies, Gareth Reginald Terrence White, Anthony John Samuel, Helen Martin · 2021 · Journal of Work-Applied Management
  54. Natural immune response and protection from SARS-CoV-2 reinfection
    Katia Margiotti, Marco Fabiani, Alvaro Mesoraca, Claudio Giorlandino · 2021 · Acta Virologica
  55. A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
    Ren-Jie Xu, Ben-Nan Zhao, Li-Juan Lan, Ya-Ling Liu, Ya-Lun Li, Liang-Shuang Jiang, Shui-Ping Dai · 2022 · International Journal of Medical Sciences
  56. Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
    John Kimotho, Yiakon Sein, Shahin Sayed, Reena Shah, Kennedy Mwai, Mansoor Noorali Saleh, Perpetual Wanjiku, Jedidah K. Mwacharo, James Nyagwange, Henry Karanja et al. · 2023 · Wellcome Open Research
  57. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
    Claudia Colombo, Laura Garatti, Giulia Ferrante, Francesca Casadei, Claudio Montalto, Gabriele Crimi, Chiara Beatrice Cogliati, Enrico Ammirati, Stefano Savonitto, Nuccia Morici · 2021 · PubMed Central
  58. Inmunología en COVID-19; mucho más allá del diagnóstico de la infección o de la vacunación
    Natalia Egri, Manel Juan · 2021 · Medicina Clínica
  59. The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
    Adam Tworek, Krzysztof Jaroń, Małgorzata Cicha, Andrzej Rydzewski, Waldemar Wierzba, Artur Zaczyński, Zbigniew J. Król, Grażyna M. Rydzewska · 2023 · Central European Journal of Immunology
  60. [Susceptibility of animal species to experimental SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) infection].
    N. Petrova, K. Ganina, S. Tarasov · 2021 · Voprosy virusologii
  61. Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases
    Ziyang Xu, Michelle Ho, Devivasha Bordoloi, Sagar B. Kudchodkar, Makan Khoshnejad, Leila B. Giron, Faraz I. Zaidi, Moonsup Jeong, Christine C. Roberts, Young K. Park et al. · 2021 · Methods in molecular biology
  62. Therapeutic Plasma Exchange Using Convalescent Plasma Replacement Therapy in Severe COVID-19 Infections: A Potential Therapeutic Option
    Joy Varghese, Subramanian Pushkala, Jayanthi Venkataraman · 2021 · EMJ Innovation
  63. 'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19
    Pablo García-Valtanen, Christopher M. Hope, Makutiro Ghislain Masavuli, Arthur Eng Lip Yeow, Harikrishnan Balachandran, Zelalem Addis Mekonnen, Zahraa Al-Delfi, Arunasingam Abayasingam, David Agapiou, Jason Gummow et al. · 2021 · SSRN Electronic Journal
  64. BOOGIE: A New Blockchain Application for Health Certificate Security
    Vito Nicola Convertini, Vincenzo Dentamaro, Donato Impedovo, Ugo Lopez, Michele Scalera, Andrea Viccari · 2024 · Lecture notes in networks and systems
  65. [Acute respiratory viral infections in monkeys].
    D. I. Dogadov, K. Kyuregyan, A. A. Minosyan, A. M. Goncharenko, Elena V. Shmat, M. I. Mikhailov · 2025 · Voprosy virusologii
  66. Translational research on pandemic virus infection using nonhuman primate models
    Hirohito Ishigaki, Yasushi Itoh · 2025 · Virology
  67. Human Challenge Studies with Coronaviruses Old and New
    Richard McKendry, Nana‐Marie Lemm, Loukas Papargyris, Christopher Chiu · 2021 · Current topics in microbiology and immunology
  68. Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model
    Emiko Urano, Tomotaka Okamura, Mahoko Higuchi, Mugi Furukawa, Kayoko Ueda, Satoshi Nagata, Haruhiko Kamada, Yasuhiro Yasutomi · 2026 · Communications Biology
  69. Prolonged dysregulation and pathological changes in the upper respiratory tract of SARS-CoV-2 infected hamsters
    Feifei Liu, Yao Xia, Andrew Chak-Yiu Lee, Yanxia Chen, Zhe Chen, Yixin He, Celia Hoi-Ching Chan, Jianpiao Cai, Terrence Tsz‐Tai Yuen, Zi‐Wei Ye et al. · 2026 · npj Viruses
  70. Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans
    Ugo Avila-Ponce de León, Shadisadat Esmaeili, Katherine L. Owens, Joshua Tisdell Schiffer · 2026 · Antimicrobial Agents and Chemotherapy
  71. Zoonotic and Reverse Zoonotic Transmission of SARS-CoV- Virus: A Perspective on Human-animal Interface
    2023 · International Journal of Agriculture and Biosciences
  72. Modeling Growth, Containment and Decay of the COVID-19 Epidemic in Italy
    Francesco Capuano · 2020 · Frontiers in Physics
  73. Evidence for immunity to SARS-CoV-2 from epidemiological data series
    Pablo Yubero, Alvar A. Lavin, Juan F. Poyatos · 2021 · F1000Research
  74. Epidemiology of COVID-19 in Latin America
    Alfonso Javier Rodriguez-Morales, D. Katterine Bonilla‐Aldana · 2021 · Elsevier eBooks
  75. 19. Einsatz gentechnologischer Methoden in der Impfstoffentwicklung gegen das SARS-CoV-2-Virus
    Martin Körte · 2021 · Nomos Verlagsgesellschaft mbH & Co. KG eBooks
  76. COVID-19, Australia: Epidemiology Report 23 (Fortnightly reporting period ending 16 August 2020).
    COVID-19 National Incident Room Surveillance Team · 2020 · Communicable diseases intelligence
  77. Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual
    Ling Ni, Fang Ye, Qin Qiao, Feng Yu, Yazheng Yang, Hui John Zhao, Li-nan Zhang, Meng‐Li Cheng, Gengzhen Zhu, Xiaoli Li et al. · 2022 · National Science Open
  78. Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination
    Natalia Egri, Manel Juan · 2022 · Medicina Clínica (English Edition)
  79. Reinfection by SARS CoV2 in Valle Del Cauca, Colombia: A Descriptive Retrospective Study
    Isabel Cristina Hurtado, Juan Sebastián Hurtado, Sandra Lizeth Valencia, Elisa María Pinzón, Ana Roció Guzmán, María Cristina Lesmes · 2022 · INQUIRY The Journal of Health Care Organization Provision and Financing
  80. Experimental Models of SARS-COV-2 Infection in the Central Nervous System
    Annamaria Paoletti, M. Melilli, Immacolata Vecchio · 2022 · Journal of Central Nervous System Disease
  81. A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain
    S.L. Belloch García · 2022 · Journal of Medical Microbiology
  82. SARS-Cov-2 Coronavirus Infection in Wild Animals
    Alex Lécu · 2023 · Elsevier eBooks
  83. Impacts of Covid-19 & black fungus on diabetes patients in India
    Anchana P Belmon, Jeraldin Auxillia · 2023 · African Health Sciences
  84. Re-positive discharged COVID-19 patients are at low transmission risk for SARS-CoV-2 infection– a finding from recovered COVID-19 patients in Wuhan, China
    Sheng Wei, Yeqing Tong, Jiafa Liu, Xuhua Guan, Siquan Wang, Bo Ram Yang, Xingxing Lu, Gaoming Wang, Qinhua Chen, Dandan Xu et al. · 2020
  85. SARS-CoV-2 Infection Elicits a Greater Humoral Immune Response in the Second Wave Than the First Wave
    Sayeh Ezzikouri, Hind Majidi, Soad Redwane, Nadia Meziane, Abdellatif Zahir, Islam Abbadi, Chaimaa Zerrad, Asmaa Haddaji, Karima Abounouh, Soufiane Hilmi et al. · 2021 · Research Square
  86. SARS-CoV-2 Infection Elicits A Greater Humoral Immune Response In The Second Wave Than The First Wave In Morocco
    Sayeh Ezzikouri, Hind Majidi, Soad Redwane, Nadia Meziane, Abdellatif Zahir, Islam Abbadi, Chaimaa Zerrad, Asmaa Haddaji, Karima Abounouh, Soufiane Hilmi et al. · 2021 · Research Square
  87. Lack of Convincing Evidence That the Widely Used COVID-19 Vaccines Will Produce Herd Immunity
    Gary P. Wormser, Catherine A. Flatley, Elizabeth M. Flatley, Patricia A. White, Marisa A. Montecalvo · 2022 · The American Journal of Medicine
  88. Review 1: A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions
    2020 · Experimental Results
  89. Review 2: A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions
    2020 · Experimental Results
  90. Review 3: A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions
    2020 · Experimental Results
  91. Vacunas contra COVID19. Una carrera contra el tiempo
    Xavier Sáez‐Llorens · 2020 · Revista médica de Panamá
  92. Akut- und Langzeitimmunität – was serologische Tests wirklich über den Immunstatus preisgeben
    Mara Klöhn, Eike Steinmann, Stephanie Pfaender · 2021 · Aktuelle Kardiologie
  93. First Potential Reinfection Case with SARS-Cov-2 in Lebanon: A Case Study
    Fadi Abdel‐Sater · 2021 · Biomedical Journal of Scientific & Technical Research
  94. Statistical dynamics of social distancing in SARS-CoV-2 as a differential game
    Csefalvay Cv · 2020 · arXiv (Cornell University)
  95. Network Analysis of SFU Course Registrations
    William E. Ruth, Richard Lockhart · 2021 · arXiv (Cornell University)
  96. Role of syrian hamsters and nonhuman primates in covid-19 research
    Deepak Y. Patil, Sreelekshmy Mohandas, Pragya Dhruv Yadav · 2021 · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases
  97. Development and Validation of a Risk Prediction Model for Patients with COVID-19 Using Linked Population Health Data (Preprint)
    Nikolaos Mastellos, Richard Betteridge, Prasanth Peddaayyavarla, Andrew Edward Moran, Jurgita Kaubryte, Justine Patterson, Esther Gathogo · 2021
  98. SARS‐CoV‐2: the prospects of the virus spreading and the course of the pathogenesis of coronavirus infection in various species of animals
    Marina S. Fedotova, А. Yu. Filippova, Magomed A. Omarov, Kseniya S. Yurchenko, Marina A. Gulyaeva · 2022 · South of Russia ecology development
  99. COVID-19 Reinfection in 60-Year-Old Man with Diabetes Mellitus, East Nusa Tenggara, Indonesia
    Heri Sutrisno Prijopranoto, Albert William Hotomo · 2021 · Advanced Biomedicine
  100. Utilizing the K18-hACE2 mouse model to develop protective COVID-19 vaccines
    Ting Y. Wong · 2022